Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Medtronic Begins BRAIVE Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has enrolled […]
Imfinzi Plus Chemotherapy Tripled Patient Survival at Three Years in the CASPIAN Phase III Trial in Extensive-stage Small Cell Lung Cancer
Updated results from the CASPIAN Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice […]
NHS Launches World’s Largest Trial of Cancer Blood Test
The NHS will today launch the world’s largest trial of a revolutionary new blood test […]
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV […]
Verily to Acquire SignalPath, Expanding Company's Clinical Research Capabilities
Verily, an Alphabet company, and SignalPath today announced that they have entered into an agreement […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
Cough Monitoring Smartphone App Incorporated into Year-Long Respiratory Research Trial
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team […]
GNTbm's Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer
Breast cancer is the most common cancer in women worldwide, especially in Taiwan. In 2018, Taiwan recorded 14,127 […]
New Data for Roche’s Hemlibra Reinforce Safety Profile in People with Haemophilia A
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from the final analysis of the […]
Intuitap Medical's Disruptive Spinal Tap Technology Enters Clinical Trials as they Close Successful $5.5m Series a Round of Funding Led by the Pink Ceiling and Curate Capital
IntuiTap Medical, a cutting-edge medical device company with technology poised to change the spinal tap, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more